Provided by Tiger Fintech (Singapore) Pte. Ltd.

Brainstorm Cell Therapeutics

0.8600
-0.0160-1.83%
Post-market: 0.89990.0399+4.64%17:33 EDT
Volume:83.92K
Turnover:74.01K
Market Cap:5.61M
PE:-0.37
High:0.9140
Open:0.9140
Low:0.8500
Close:0.8760
Loading ...

BrainStorm submits IND amendment to FDA for Phase 3b trial of NurOwn in ALS

TIPRANKS
·
10 Apr

Brainstorm Cell Therapeutics Submits Ind Amendment to FDA, Paving the Way for Phase 3B Trial of Nurown® in ALS

THOMSON REUTERS
·
10 Apr

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Brainstorm Cell Therapeutics (BCLI)

TIPRANKS
·
10 Apr

Brainstorm Cell Therapeutics Inc (BCLI) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
01 Apr

Q4 2024 Brainstorm Cell Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Apr

Brainstorm Cell Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
31 Mar

Press Release: BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
31 Mar

Brainstorm Cell Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
28 Mar

Brainstorm Cell Therapeutics Granted Compliance Extension From Nasdaq

THOMSON REUTERS
·
26 Mar

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

PR Newswire
·
26 Mar

Brainstorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

THOMSON REUTERS
·
24 Mar

BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

PR Newswire
·
24 Mar

BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…

Zacks Small Cap Research
·
06 Jan

BrainStorm Issues 2024 Letter to Shareholders

PR Newswire
·
30 Dec 2024

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)

TIPRANKS
·
15 Dec 2024

Brainstorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

THOMSON REUTERS
·
09 Dec 2024

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

PR Newswire
·
09 Dec 2024

BRIEF-Brainstorm Strengthens Exosome Patent Portfolio, Receives Notice Of Allowance For U.S. Patent Covering Its Platform Technology

Reuters
·
03 Dec 2024

BrainStorm receives Notice of Allowance for patent on exosome technology

TIPRANKS
·
03 Dec 2024

Brainstorm: Strengthens Exosome Patent Portfolio, Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

THOMSON REUTERS
·
03 Dec 2024